Drug details

Doryx (doxycycline hyclate)

type of Tetracyclines

Doryx MPC (doxycycline hyclate delayed-release tablets) is a tetracycline class antibiotic indicated for rickettsial infections, sexually transmitted infections, respiratory tract infections, specific bacterial infections, ophthalmic infections anthrax [including inhalational anthrax (post-exposure)], alternative treatment for selected infections when penicillin is contraindicated, adjunctive therapy in acute intestinal amebiasis and severe acne, and prophylaxis of malaria. Doryx MPC is available in generic form.

The drug is often used to treat Malaria .

This drug may have the following side effects:

• nausea,
• vomiting,
• diarrhea,
• loss of appetite,
• rash,
• hives, and
• photosensitivity,
• hemolytic anemia.

The following drugs are related to Doryx, either as a replacement or used together:

• Augmentin (amoxicillin clavulanate)
• Anthrasil (anthrax immune globulin intravenous (human), sterile solution for infusion)
• Arestin (minocycline hydrochloride microspheres)
• Cinobac (cinoxacin)
• Diflucan (fluconazole)
• Vibramycin (doxycycline calcium oral)
• Vibramycin Intravenous (doxycycline hyclate)
• Okebo (doxycycline monohydrate capsules)
• Halfan (halofantrine hydrochloride tablets)
• Raxibacumab (human igg1λ monoclonal antibody intravenous infusion)
• Levaquin (levofloxacin)
• Zilxi (minocycline topical foam)
• Moxidectin (moxidectin tablets)
• Sumycin (tetracycline)